|
| Title |
|
|
|
Discovery of novel 7-aryl 7-deazapurine 3′-deoxy-ribofuranosyl nucleosides with potent activity against Trypanosoma cruzi
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Journal of medicinal chemistry. - Washington, D.C., 1963, currens | |
| Publication |
|
|
|
Washington, D.C. : 2018
| |
| ISSN |
|
|
|
0022-2623
| |
| Volume/pages |
|
|
|
61:20(2018), p. 9287-9300
| |
| ISI |
|
|
|
000448754900020
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (open access) |
|
|
|
| The author-created version that incorporates referee comments and is the accepted for publication version Available from 21.09.2019 | | |
| Full text (publisher's version - intranet only) |
|
|
| | |
|
| Faculty/Department |
|
|
| | |
| Research group |
|
|
|
| Project info |
|
|
|
Veterinary and human parasitology. Modified 7-deazapurine nucleoside analogues for the treatment of human African trypanosomiasis: towards a strong proof-of-concept.
| Publication type |
|
|
| | | |
| Subject |
|
|
|
| | |
| Affiliation |
|
|
|
Publications with a UAntwerp address
| |
|
|
|
| Identification |
|
| |
|
|
| Creation |
|
| |
29.10.2018
|
|
| Last edited |
|
| |
11.12.2018
|
|
| To cite this reference |
|
|
| | |
|
| |